Evidence map›Paper›PMID 42429407›Full record

ArticleMicrobiology spectrum2026

Genomic analysis of community-associated multidrug-resistant

Jianping Jiang, Austin J Terlecky, Elena Shashkina, Meghan W Starolis, Liang Chen, Barry N Kreiswirth

Abstract read
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jianping JiangCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
Austin J TerleckyCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.ORCID 0009-0005-8209-8922
Elena ShashkinaCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
Meghan W StarolisQuest Diagnostics, Secaucus, New Jersey, USA.ORCID 0009-0002-7648-2037
Liang ChenSchool of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA.ORCID 0000-0001-5845-2235
Barry N KreiswirthCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.ORCID 0000-0002-0243-131X

Funding

Dissecting the host-plasmid interplay to unravel the spread of ESBL-producing K. pneumoniaeU01AI187297 · NIAID · HACKENSACK UNIVERSITY MEDICAL CENTER · PI BARRY Neal KREISWIRTH · 2025 to 2026
$1.7M
Innovative Antibiotic Combinations for Hypervirulent Klebsiella pneumoniaeR21AI190454 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BULMAN, ZACKERY P., CHEN, LIANG · 2025 to 2025
$457k
National Institute of Allergy and Infectious Diseases R21AI190454National Institute of Allergy and Infectious Diseases U01AI187297NIAID NIH HHS R21 AI190454NIAID NIH HHS U01 AI187297
6 · The paper itself

Abstract

IMPORTANCE:

Indexed as

Community-Acquired InfectionsDrug Resistance, Multiple, BacterialKlebsiellaKlebsiella InfectionsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesGenome, BacterialGenomicsHumansMicrobial Sensitivity TestsUnited StatesWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesKL1Klebsiella quasipneumoniae subsp. similipneumoniaemultidrug-resistantST2059

Identifiers

PMID42429407
PMCPMC13436224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.